As biotechnology, diagnostics, and pharmaceutical research pipelines expand globally, laboratories are consuming disposable supplies at a faster pace than ever, and the lab consumables market is scaling to match that demand. Kings Research values the global market at USD 14.83 billion in 2023, with growth to USD 15.83 billion in 2024 and further to USD 25.53 billion by 2031, representing a CAGR of 7.07% over the forecast period. The expansion reflects rising laboratory activity across clinical research, molecular biology, and genomics, alongside the growing adoption of automation technologies that require specialized, compatible consumables.
What Falls Under “Lab Consumables”
Lab consumables are essential, typically single-use items with a limited lifespan that require regular replenishment—pipettes, test tubes, petri dishes, gloves, and reagents among them. Unlike reusable lab equipment, consumables are designed for short-term use and play a foundational role in maintaining sterile environments, ensuring accurate measurements, and enabling reliable experimentation across research, diagnostics, clinical testing, and drug development. Their consistent, recurring demand across virtually every laboratory setting makes them a resilient revenue category even during broader economic uncertainty.
R&D Spending Is the Primary Growth Engine
Rising investment in research and development within biotechnology and pharmaceutical companies is the market’s central driver. As organizations intensify focus on drug discovery, genetic research, and clinical trials, demand for pipettes, reagents, petri dishes, and test tubes—materials essential to conducting experiments and generating reliable data—continues to climb. Biopharmaceutical R&D spending alone was estimated at more than USD 202 billion globally, a figure that surpasses R&D investment in industries such as aerospace, defense, chemicals, and software, underscoring the scale of the demand base supporting consumables consumption.
Growing R&D pipelines in biologics and personalized medicine are particularly consumables-intensive, given the iterative, high-throughput nature of experimentation these fields require. Advancements in genomics and molecular biology are compounding this effect, steadily pushing consumables demand higher across both academic and commercial laboratory settings.
Segment Analysis: Reagents and Pharma Applications Lead
By type, reagents and kits led the market in 2023 with a valuation of USD 6.90 billion, propelled by the rising prevalence of chronic diseases and the growing focus on personalized medicine, both of which increase demand for specialized reagents and kits in molecular biology, clinical diagnostics, and biopharmaceutical applications. Continued innovation in reagent formulations and more user-friendly kit designs are further enhancing adoption across academic and commercial labs alike.
By application, the pharmaceutical industry segment—spanning pharmaceuticals, biotechnology, environmental testing, and material science—captured the largest revenue share in 2023 at 51.46%. Rising R&D investment, particularly in drug discovery and clinical trials, along with regulatory requirements for quality control and compliance, is compelling pharmaceutical companies to expand laboratory capacity and invest in higher-quality consumables to ensure accuracy and reliability in their testing processes.
Sustainability and Automation: Two Defining Trends
Environmental pressure is reshaping product development across the sector. As laboratories face growing pressure to reduce waste and comply with stricter environmental regulations, demand for biodegradable and recyclable consumables—eco-friendly pipettes and test tubes among them—is rising. This shift is attracting new customer segments, including research institutions and companies with explicit sustainability commitments, and is gradually establishing a distinct green-consumables niche within the broader market.
Automation is the second major trend reshaping demand patterns. Automated liquid handling systems, robotics, and high-throughput screening equipment require precise, compatible consumables—specialized pipette tips, plates, and tubes engineered for these systems. As laboratories increasingly emphasize automation in drug discovery, genomics, and clinical diagnostics to improve efficiency, accuracy, and scalability, demand for consumables tailored specifically to automated workflows continues to grow, creating a premium sub-segment within the broader market.
Cost Pressures and Regulatory Complexity
Rising raw material costs represent a persistent headwind, increasing production expenses and, ultimately, prices for end users. Stringent regulatory requirements around product quality and safety add further complexity to manufacturing processes, often extending development timelines. Combined with intensifying competition that can compress profit margins, these pressures are prompting manufacturers to invest heavily in identifying alternative, cost-effective materials and improving manufacturing efficiency. Many are also adopting eco-friendly practices to simultaneously address sustainability goals and regulatory compliance, while deepening supplier collaborations to enhance resource stability.
Regional Landscape
North America led the global market in 2023 with a 41.28% share, valued at USD 6.12 billion, driven largely by expanding investment in research, development, and biomanufacturing. A single U.S. government biomanufacturing initiative committed more than USD 2 billion to enhance manufacturing capacity and support life-sciences innovation, a scale of investment expected to sustain elevated consumables demand as companies expand operations to meet regulatory and production requirements. The concentration of major pharmaceutical and biotechnology firms in the region further reinforces a competitive landscape that drives continuous consumables innovation.
Asia-Pacific is projected to be the fastest-growing region, expanding at an 8.41% CAGR through 2031, supported by rapidly expanding healthcare infrastructure and rising investment in medical facilities. China alone had more than 1.07 million medical and health facilities by the end of 2023, including 39,000 hospitals and over 1 million grassroots clinics and community health centers—an extensive network that significantly amplifies demand for reagents, diagnostic kits, and other consumables across the region.
Competitive Landscape
The market remains fragmented, with major players—including Abbott, Bio-Rad Laboratories, Agilent Technologies, Merck KGaA, Eppendorf, Corning, QIAGEN, Bruker, and Waters—pursuing partnerships, acquisitions, and product innovation to expand their portfolios and strengthen regional market share. A notable recent development includes the launch of semi-skirted PCR plates made from bio-circular polymers, reflecting the industry’s broader move toward sustainable consumables that maintain high analytical performance while reducing environmental impact.
Conclusion
With biotechnology and pharmaceutical R&D spending continuing to climb globally, and laboratories increasingly adopting automated, high-throughput workflows, the lab consumables market’s trajectory toward USD 25.53 billion by 2031 appears well-supported by durable underlying demand. As sustainability considerations and automation compatibility become standard purchasing criteria, manufacturers that can deliver both performance and environmental responsibility are likely to capture a disproportionate share of this expanding market.